pristiq extended-release
Generic: desvenlafaxine succinate
Labeler: wyeth pharmaceuticals llc, a subsidiary of pfizer inc.Drug Facts
Product Profile
Brand Name
pristiq extended-release
Generic Name
desvenlafaxine succinate
Labeler
wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
desvenlafaxine succinate 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0008-1222
Product ID
0008-1222_1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021992
Listing Expiration
2026-12-31
Marketing Start
2008-05-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00081222
Hyphenated Format
0008-1222
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pristiq extended-release (source: ndc)
Generic Name
desvenlafaxine succinate (source: ndc)
Application Number
NDA021992 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01)
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-14)
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-30)
- 100 BLISTER PACK in 1 CARTON (0008-1222-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Packages (4)
0008-1222-01
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01)
0008-1222-14
14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-14)
0008-1222-30
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-30)
0008-1222-50
100 BLISTER PACK in 1 CARTON (0008-1222-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f", "openfda": {"upc": ["0300081210306", "0300081222309", "0300081211303"], "unii": ["ZB22ENF0XR"], "rxcui": ["790267", "790290", "1607617", "1607619", "1874553", "1874559"], "spl_set_id": ["0f43610c-f290-46ea-d186-4f998ed99fce"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01)", "package_ndc": "0008-1222-01", "marketing_start_date": "20080501"}, {"sample": false, "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-14)", "package_ndc": "0008-1222-14", "marketing_start_date": "20080501"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-30)", "package_ndc": "0008-1222-30", "marketing_start_date": "20080501"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0008-1222-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0008-1222-50", "marketing_start_date": "20080501"}], "brand_name": "Pristiq Extended-Release", "product_id": "0008-1222_1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "0008-1222", "generic_name": "desvenlafaxine succinate", "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pristiq", "brand_name_suffix": "Extended-Release", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "100 mg/1"}], "application_number": "NDA021992", "marketing_category": "NDA", "marketing_start_date": "20080501", "listing_expiration_date": "20261231"}